← All indications
Osteonecrosis
Death of a bone or part of a bone, either atraumatic or posttraumatic.
Subtype terms (2)
More specific conditions that are subtypes of Osteonecrosis in the MeSH hierarchy.
- Bisphosphonate-Associated Osteonecrosis of the Jaw
5 drugs approved
- Femur Head Necrosis
14 drugs (9 approved, 5 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (4)
Phase 2 trials (7)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (20)
- Novartis
- Sclnow Biotechnology Co., Ltd.
- Vericel Corporation
- National Cancer Institute (NCI)
- Banc de Sang i Teixits
- Federal University of Bahia
- Jilin University
- Johns Hopkins University
- New York University
- Universidad Autonoma de Madrid
- University of Ottawa
- University of Sydney
- Inner Mongolia International Mongolian Hospital
- Universidad Autonoma de Barcelona
- Erasmus University Rotterdam
- University of Liege
- European Regional Development Fund
- Government of Spain
- Oswaldo Cruz Foundation
- St. Jude Children's Hospital
Organization Involved with Phase 1 Indications (11)
- Red de Terapia Celular
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Royan Institute
- Spanish National Health System
- Universidad de Murcia
- University of Tehran
- University of California, Davis
- California Institute for Regenerative Medicine
- Public Health Service, Murcia
- People's Liberation Army of China
- Fuzhou Infectious Diseases Hospital
Organization Involved with Other Experimental Indications (7)